These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6310952)
1. [Kinetic study of the hydrolysis of pipecuronium bromide. I Separation and quantitative determination of pipecuronium bromide and its hydrolysis-derivatives by thin-layer chromatography and densitometry]. Kovács P; Takácsi Nagy G Acta Pharm Hung; 1983 Mar; 53(2):56-63. PubMed ID: 6310952 [No Abstract] [Full Text] [Related]
2. [Kinetic study of the hydrolysis of pipecuronium bromide. III. General acid-base catalysis, effect of the solvent on the rate of hydrolysis]. Kovács P; Takácsi Nagy G; Horváth P Acta Pharm Hung; 1983 Mar; 53(2):71-85. PubMed ID: 6310954 [No Abstract] [Full Text] [Related]
3. [Kinetic study of the hydrolysis of pipecuronium bromide. II. Specific acid-base catalysis]. Kovács P; Takácsi Nagy G; Horváth P Acta Pharm Hung; 1983 Mar; 53(2):64-70. PubMed ID: 6310953 [No Abstract] [Full Text] [Related]
4. [Analysis of steroids. Part 45: Analytical investigation of pipecuronium bromide (Arduan)]. Gazdag M; Szepesi G; Mihályfi K; Kemenesné BP; Horváth P; Végh Z; Rényei M; Trischler F; Görög S Acta Pharm Hung; 1992 May; 62(3):88-96. PubMed ID: 1323918 [TBL] [Abstract][Full Text] [Related]
5. Determination of Arduan and its desacetyl metabolites in biological fluids. Gábor S; László V Acta Pharm Hung; 1989 Jul; 59(4):167-72. PubMed ID: 2549761 [TBL] [Abstract][Full Text] [Related]
6. Determination of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in human serum. Szabó G; Tassonyi E Arzneimittelforschung; 1981; 31(6):1013-5. PubMed ID: 6266429 [TBL] [Abstract][Full Text] [Related]
7. Clinical experiences with pipecuronium bromide. Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of steroids. Part 44: Analytical investigation of the intermediates of the synthesis of pipecuronium bromide (Arduan)]. Laukó A; Horváth P; Trischler F; Görög S Acta Pharm Hung; 1992 May; 62(3):82-7. PubMed ID: 1323917 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans. Tassonyi E; Szabó G; Vereczkey L Arzneimittelforschung; 1981; 31(10):1754-6. PubMed ID: 6274362 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of pipecurium bromide in the rat. Bodrogi L; Fehér T; Váradi A; Vereczkey L Arzneimittelforschung; 1980; 30(2a):366-70. PubMed ID: 6248081 [No Abstract] [Full Text] [Related]
11. Experience with Arduan in anaesthesiology. Kovács L Ther Hung; 1984; 32(2):65-8. PubMed ID: 6100821 [No Abstract] [Full Text] [Related]
12. [A pharmacodynamic study of pipecuronium bromide (Arduan) in newborn infants, infants and children]. Praefort L Cah Anesthesiol; 1990 Mar; 38(2):79-85. PubMed ID: 2163731 [TBL] [Abstract][Full Text] [Related]
13. Observations on the neuromuscular blocking action of pipecuronium in the dog. Jones RS Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005 [TBL] [Abstract][Full Text] [Related]
14. [Use of the steroid muscle relaxant arduan in surgical interventions on the musculoskeletal system]. Pashchuk AIu; Tiutiunnik IF; Zgola IA Ortop Travmatol Protez; 1984 Dec; (12):20-2. PubMed ID: 6098888 [No Abstract] [Full Text] [Related]